Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Laboratory Corp. Of America Holdings (NYSE: LH) closed at $198.35 down -4.61% from its previous closing price of $207.94. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 2.1 million shares were traded. LH stock price reached its highest trading level at $204.82 during the session, while it also had its lowest trading level at $196.11.
Ratios:
For a deeper understanding of Laboratory Corp. Of America Holdings’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 31.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.08. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.61.
On February 26, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $260.
On February 09, 2024, Evercore ISI started tracking the stock assigning a In-line rating and target price of $240.Evercore ISI initiated its In-line rating on February 09, 2024, with a $240 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 01 ’24 when Schroeder Mark S sold 6,477 shares for $217.29 per share. The transaction valued at 1,407,387 led to the insider holds 5,036 shares of the business.
Summy Amy B. sold 3,500 shares of LH for $760,515 on Apr 01 ’24. The EVP, Chief Marketing Officer now owns 3,975 shares after completing the transaction at $217.29 per share. On Mar 28 ’24, another insider, van der Vaart Sandra D, who serves as the EVP, Chief Legal Officer of the company, sold 3,553 shares for $216.74 each. As a result, the insider received 770,077 and left with 7,637 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 16686373888 and an Enterprise Value of 22920654848. As of this moment, Laboratory’s Price-to-Earnings (P/E) ratio for their current fiscal year is 42.63, and their Forward P/E ratio for the next fiscal year is 12.39. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.29 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 1.885 whereas that against EBITDA is 14.161.
Stock Price History:
Over the past 52 weeks, LH has reached a high of $234.09, while it has fallen to a 52-week low of $179.58. The 50-Day Moving Average of the stock is -6.82%, while the 200-Day Moving Average is calculated to be -6.97%.
Shares Statistics:
For the past three months, LH has traded an average of 751.06K shares per day and 880080 over the past ten days. A total of 83.90M shares are outstanding, with a floating share count of 83.77M. Insiders hold about 0.39% of the company’s shares, while institutions hold 98.48% stake in the company. Shares short for LH as of 1713139200 were 2263979 with a Short Ratio of 3.01, compared to 1710460800 on 1985241. Therefore, it implies a Short% of Shares Outstanding of 2263979 and a Short% of Float of 3.66.
Dividends & Splits
According to the company, the forward annual dividend rate for LH is 2.88, from 2.88 in the trailing year. Against a Trailing Annual Dividend Yield of 0.01385015
